| ORIGINAL ARTICLE |
|
| Year : 2010 | Volume
: 1
| Issue : 3 | Page : 330-333 |
|
|
Assessment of the antidiabetic potential of Cassia grandis using an in vivo model
Sandesh R Lodha1, Shrikant V Joshi1, Bhavin A Vyas1, Mohini C Upadhye2, Megha S Kirve2, Shweta S Salunke2, Sheetal K Kadu2, Manasi V Rogye2
1 Department of Pharmaceutical Chemistry, Maliba Pharmacy College, Gopal Vidyanagar, Tarsadi, Gujarat, India
2 Department of Pharmaceutical Chemistry, Modern College of Pharmacy (for ladies), Moshi, Pune, Maharashtra, India
Correspondence Address:
Sandesh R Lodha
Maliba Pharmacy College, Gopal Vidyanagar, Tarsadi - 394 350, Gujarat
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0110-5558.72429
|
|
|
The aqueous and ethanolic extracts of C. grandis (Family: Leguminosae) were evaluated for antidiabetic activity by a glucose tolerance test, in normal rats and alloxan-induced diabetic rats. The aqueous and ethanolic extracts showed that they significantly lowered the blood glucose levels to normal in the glucose tolerance test. In alloxan-induced diabetic rats the maximum reduction in blood glucose was observed after three hours, at a dose level of 150 mg/kg of body weight. The percentage of protection given by the aqueous and ethanolic extracts was 32.72 and 46.42%, respectively. In the long-term treatment of alloxan-induced diabetic rats, the degree of protection was determined by measuring the blood glucose, cholesterol, and triglycerides on the tenth day. Both the extracts showed a significant antidiabetic activity comparable to that of glibenclamide. These results showed that the Cassia grandis possessed significant antidiabetic activity. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
